Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report

RATIONALE: Although immunomodulatory therapy has been clearly stated as an important landmark in treatment of ulcerative colitis, significantly improving the quality of life for patients with inflammatory bowel disease, there are several aspects to be considered regarding the possible side-effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gîlcă, Georgiana-Emmanuela, Diaconescu, Smaranda, Bălan, Gheorghe Gh., Timofte, Oana, Ştefănescu, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348151/
https://www.ncbi.nlm.nih.gov/pubmed/28272203
http://dx.doi.org/10.1097/MD.0000000000006156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348151/
https://www.ncbi.nlm.nih.gov/pubmed/28272203
http://dx.doi.org/10.1097/MD.0000000000006156

Ejemplares similares